Fresenius medical care's third-party clinical research organization frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care

Frenova and nephronomics, a renal precision company co-founded by fresenius medical care, initiate collaboration with genewiz by azenta life sciences provides vital insights through sophisticated genomic sequencing and analysis of frenova's my reason® genomic and clinical data registry paves way for advances in precision kidney disease care, novel therapies, and diagnostics bad homburg, germany , july 31, 2025 /prnewswire/ -- fresenius medical care today announced that frenova, the company's third-party clinical research organization, along with nephronomics, a renal precision medicine company, and genewiz by azenta life sciences, have entered a collaboration to advance the genomic analysis efforts for frenova's transformative my reason® genomics research program. this strategic collaboration aims to leverage cutting-edge technologies to better understand kidney, cardiovascular, and metabolic diseases while driving advancements in precision medicine for patients worldwide.
AZTA Ratings Summary
AZTA Quant Ranking